~~<i id='CB62C4B296'><strike id='CB62C4B296'><tt id='CB62C4B296'><pre id='CB62C4B296'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：hotspot 2025-09-28 04:58:53 - browse：84542

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： IRA could hurt research into orphan drugs for rare diseases

explore

hotspot

knowledge

hotspot

leisure time

Michel,acysticfibrosispatientfromMascouche,Québec,Canada,seenhereatoneoftheclinicsthatcontributeddat

WSS

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

New Covid vaccine is recommended for everyone 6 months or older

'Screen and refer' systems are hurting patients

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Undocumented workers face uncertainty as immigration law takes effect in Florida

What affirmative action's end means to a medical student

focus

knowledge

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Hospitals consider fixing cancer drug shortages on their own

Virginia high school admissions case could be legal follow

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

23andMe had bad news about my health. I wish a person had delivered it

Prescription digital therapeutics are key to pharma’s future

Guidelines to prevent youth baseball injuries need more muscle

Food makers tried to stack nutrition panel with preferred experts

Medicare details structure of new drug price negotiation program

Prescription digital therapeutics are key to pharma’s future

hotspot

How Robert F. Kennedy Jr. distorted vaccine science

Use doctors trained outside the U.S. to ease the physician shortage

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Canadians with cystic fibrosis outlive Americans by a decade

STAT wants to know your pick for a great summer read or listen

Food makers to regulators: Ultra

knowledge

hotspot

leisure time

leisure time